Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06654713 · ClinicalTrials.gov registry record
Commercial or Open Source Closed Loop Impact on Pregnancy Study
A clinical trial of Type 1 Diabetes and Pregnancy Related, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06654713: Recruiting study of Type 1 Diabetes and Pregnancy Related, sponsored by University of California, San Francisco.
NCT06654713 is a study of Type 1 Diabetes and Pregnancy Related that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 1,000 participants, above the 762-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (31% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06654713, a study of Type 1 Diabetes and Pregnancy Related, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to better understand what happens when pregnant people with type 1 diabetes (T1D) use automated insulin delivery (AID) systems. The main questions this study aims to answer are: * What are the maternal and neonatal outcomes with AID system use in pregnancy? * What are the glycemic outcomes with AID system use in pregnancy? * What are the behavioral and emotional outcomes with AID system use in pregnancy? Researchers will compare pregnant people who use commercial AID systems and pregnant people who use open source AID systems to see if outcomes are different with these different types of systems. Participants will be asked to remotely share their AID system data with the research team; complete online surveys regarding behavioral and emotional health; and sign an authorization to release health information to allow the research team to access medical records.
Primary Outcome
Primary neonatal outcome. LGA defined as birth weight \> 90th percentile for gestational age
Conditions Studied
Interventions
- OTHER Commercial AID system
- OTHER Open source AID system
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2029-12-31 |
What NCT06654713 shows while recruiting
NCT06654713 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 762-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (31% higher).
The record links to 4 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Commercial AID system is the first listed.
NCT06654713 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06654713 about?
NCT06654713 is a clinical study titled "Commercial or Open Source Closed Loop Impact on Pregnancy Study". The goal of this observational study is to better understand what happens when pregnant people with type 1 diabetes (T1D) use automated insulin delivery (AID) systems. The main questions this study aims to answer are: * What are the maternal and neonatal outcomes with AID system use in pregnancy? *...
What is the current status of trial NCT06654713?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-03-13. Estimated completion is 2029-12-31.
What conditions does trial NCT06654713 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Pregnancy Related, Pregnancy, High Risk, Insulin Dependent Diabetes.
What interventions are being tested in trial NCT06654713?
The interventions under investigation include: Commercial AID system (OTHER), Open source AID system (OTHER).
Who is sponsoring clinical trial NCT06654713?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06654713 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06654713's enrollment target sits among peer trials
1,000 10th of 198 higher than 189 of 198 other Type 1 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
RECRUITING
-
Extended Bolus for Meals in a Closed-loop System
RECRUITING · Phase 4
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
AIDANET Pediatrics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI